Cardiovascular diseases are widespread and cause death for about 40 % of the population in the Western world.

The LifePod-application provides unique possibilities to improve the quality of life and prognosis in post-myocardial infarction patients. During April 2016 a research study including 250 patients starts in Scania at University Hospital; Margret Leosdotttir, cardiologist, is the main research leader for the Swedish study.

Read more about the clinical study in the magazine Dagens Medicin.